Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

MedicalXpress | 三月 26, 2026

Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as "reassuring" in a presentation at the 15th European Breast Cancer Conference (EBCC15) in Barcelona.